Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Marianna Pavani"'
Autor:
Beatrice NICCOLETTI, Marianna PAVANI, Lucia BABINI, Valentina VIOLA, Alessandra CALCINARI, Jacopo SABBATINELLI, Marco MORETTI
Publikováno v:
La Rivista Italiana della Medicina di Laboratorio.
Autor:
Alessia Ferrarini, Angelo Vacca, Antonio Giovanni Solimando, Marcello Tavio, Rossella Acquaviva, Marco Rocchi, Cinzia Nitti, Aldo Salvi, Vincenzo Menditto, Michele Maria Luchetti Gentiloni, Alessandro Russo, Marco Moretti, Marianna Pavani, Andrea Giacometti, Martina Bonifazi, Lina Zuccatosta, Laura Romani, Vito Racanelli, Gianluca Moroncini, Armando Gabrielli, Giovanni Pomponio
Publikováno v:
European Journal of Clinical Investigation. 53
Controversies on sub-populations most sensitive to therapy and the best timing of starting the treatment still surround the use of immunomodulatory drugs in COVID-19.We designed a multicentre open-label randomised controlled trial to test the effect
Autor:
Jacopo Sabbatinelli, Olga Protic, Anna Rita Bonfigli, Andrea Stronati, Marianna Pavani, Antonio Domenico Procopio, Fabrizia Lattanzio, Fabiola Olivieri, Roberto Antonicelli, Roberto Testa
Publikováno v:
Thrombosis research. 221
Direct oral anticoagulants (DOACs) are widely employed for antithrombotic prophylaxis in patients with atrial fibrillation (AF). However, there is still uncertainty about their risk-benefit profile in older patients. Here, we evaluated the efficacy,
Autor:
Giovanni M Frascà, Gabriele Polonara, Edlira Skrami, Luigi Ferrante, Simona Magi, Fabiana Brigante, Pasqualina Castaldo, Gian Marco Giuseppetti, Salvatore Amoroso, Marianna Pavani
Publikováno v:
European Radiology. 29:3927-3934
To estimate the incidence of contrast-induced acute kidney injury (CI-AKI) after intravenous (iv) iodinated contrast material (ICM) exposure. This prospective cohort study included all consecutive patients who underwent radiological investigations us
Autor:
G Titolo, F Mei, Martina Bonifazi, L Morbidoni, Donatella Amico, A Gabrielli, M Moretti, A Salvi, L Zuccatosta, M Tavio, Marcello Mario D’Errico, M Onesta, M L B Rocchi, Marianna Pavani, G Frausini, A Giacometti, V Menditto, Abele Donati, G Pomponio, A Ferrarini, Silvia Svegliati, S Menzo
Publikováno v:
Journal of Internal Medicine
Background Published reports on tocilizumab in COVID‐19 pneumonitis show conflicting results due to weak designs or heterogeneity in critical methodological issues. Methods This open‐label trial, structured according to Simon's optimal design, ai
Autor:
Marco Moretti, Silvia Baroni, Giovanni Pomponio, Antonio Domenico Procopio, Giulia Matacchione, Fabiola Olivieri, Manuela Ferracin, Marianna Pavani, Massimiliano Bonafè, Noemi Laprovitera, Angelica Giuliani, Alessia Ferrarini, Jacopo Sabbatinelli, Silvia Latini, Armando Gabrielli
Publikováno v:
Mechanisms of Ageing and Development
Highlights • Tocilizumab (TCZ) is currently being tested in COVID‐19‐induced cytokine storm. • COVID-19 patients responding to TCZ have higher post-treatment levels of circulating miR-146a. • Low levels of miR-146a are associated with death
Autor:
Donatella Amico, Federico Mei, Marcello Mario D’Errico, Stefano Menzo, Laura Morbidoni, Marco B. L. Rocchi, Vincenzo G Menditto, Giovanni Pomponio, Marco Moretti, Alessia Ferrarini, Aldo Salvi, Gabriele Frausini, Abele Donati, Silvia Svegliati, Armando Gabrielli, Lina Zuccatosta, Marcello Tavio, Andrea Giacometti, Giancarlo Titolo, Maicol Onesta, Marianna Pavani, Martina Bonifazi
Background: Multiple studies have been conducted to investigate Tocilizumab in patients with cOVID-19 pneumonitis. However, published reports show conflicting results, largely due to weak retrospective designs and heterogeneity in critical methodolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c81cdb40468948129ae2b8196d8ca9f
https://doi.org/10.21203/rs.3.rs-42117/v1
https://doi.org/10.21203/rs.3.rs-42117/v1
Autor:
Noemi Laprovitera, Giulia Matacchione, Armando Gabrielli, Silvia Latini, Manuela Ferracin, Marianna Pavani, Alessia Ferrarini, Silvia Baroni, Jacopo Sabbatinelli, Massimiliano Bonafè, Giovanni Pomponio, Fabiola Olivieri, Angelica Giuliani, Marco Moretti, Antonio Domenico Procopio
BackgroundCurrent COVID-19 pandemic poses an unprecedented threat to global health and healthcare systems. At least in western countries, the most amount of the death toll is accounted by old people affected by age-related diseases. In this regard, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa5c370ef81406109a80080418fac9e
https://doi.org/10.1101/2020.07.11.20151365
https://doi.org/10.1101/2020.07.11.20151365
Autor:
Marina Brugia, Lucia Babini, Fabiana Pasquini, Alessandra Calcinari, Marianna Pavani, Vincenzo G. Menditto, Aldo Salvi, Marco Moretti
Publikováno v:
La Rivista Italiana della Medicina di Laboratorio. 16
Autor:
John C. Burnett, Massimo Polito, Marianna Pavani, Valentina Cannone, Monica Ceresiani, Paolo Dessì-Fulgheri, Riccardo Sarzani, Daniele Minardi, Martin Wabitsch, Marica Bordicchia
Publikováno v:
American journal of physiology. Regulatory, integrative and comparative physiology. 311(1)
Cardiac natriuretic peptides (NP) are involved in cardiorenal regulation and in lipolysis. The NP activity is largely dependent on the ratio between the signaling receptor NPRA and the clearance receptor NPRC. Lipolysis increases when NPRC is reduced